(Press-News.org)
VIDEO:
Using two-photon imaging, the researchers were able to see dendritic cells, shown in green, in the intestine of a living mouse.
Click here for more information.
With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass.
Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the intestine so that the immune system doesn't mount an attack.
Their discovery, in mice, sheds new light on the function of goblet cells that line the intestine, and provides scientists with a potential target for therapies against inflammatory bowel disease, celiac disease and food allergies — disorders caused by an overactive immune system.
The researchers report their findings March 15, 2012, in the journal Nature.
"We found evidence that goblet cells work the same way in people and mice," says co-principal investigator Rodney D. Newberry, MD. "We knew that if you eat a protein or antigen, it gets taken up in the intestine by immune cells called dendritic cells, and you become tolerant to it. But we didn't know how the dendritic cells and the antigens got connected. From our experiments, it appears that goblet cells act as the matchmaker, bringing the food you eat and the dendritic cells together. That means goblet cells could become a hot target for new therapies."
Using a novel imaging technique, the scientists watched the inner workings of the intestine in a living mouse in real time. They observed as antigens from a labeled sugar ingested by the mouse were passed by goblet cells to dendritic cells.
Dendritic cells play a key role in the immune system. But until now, scientists had thought that goblet cells in the intestine had only one job — to secrete mucus.
AUDIO:
Every time we eat, cells in the intestine have to make sure that the organ doesn’t mount an immune response against the food. Immune cells in the intestine are standing...
Click here for more information.
"Everyone has concentrated only on the fact that goblet cells secrete mucus, but I think in the face of our findings, you could perhaps wonder whether the problem in inflammatory bowel disease might result in part from goblet cells not delivering antigens to the correct place," says Newberry, an associate professor of medicine in the Division of Gastroenterology. "Or maybe they're not delivering antigens at all or too many antigens. We just don't know yet."
The small intestine is like a long, coiled tube. The center of that tube, the lumen, is filled with food material and bacteria that normally don't cause disease. It's protected from harmful pathogens by a layer of mucus secreted from goblet cells.
According to co-principal investigator, Mark J. Miller, PhD, assistant professor of pathology and immunology, antigens start out on one side of that mucus barrier while the immune system's dendritic cells are on the other side. Miller and Newberry used a technique called two-photon imaging to watch as antigens were transported across that barrier.
"At any given time, there are goblet cells transporting antigens," Miller says. "And that appears to be the mechanism to deliver food antigens and maybe even self-antigens to dendritic cells to induce tolerance. If the dendritic cells have access to antigens, they can educate T-cells that these are harmless antigens rather than infectious agents."
He says the findings are important because now scientists know that immune responses in the intestine may depend as much on the ability of goblet cells to transport antigens to dendritic cells as on what the dendritic cells then do with the antigens. And Miller says no one knew that before because it only recently has become possible to watch intestinal immune cells in action in a living animal.
"This is not the role for goblet cells that we would have predicted," Miller says. "But that's the power of this type of imaging. Often, you'll come across some new phenomenon that you didn't expect. Sometimes, just by looking you realize there's more to a system than you originally thought, and that leads you in new directions."
Miller and Newberry also looked at healthy human intestinal tissue that had been removed from patients undergoing weight-loss surgery. It became clear from this work that goblet cells perform the same function in people as in mice, which raises the prospect that the cells may be valid drug targets for treating inflammatory bowel disease and other intestinal problems caused by an over-stimulated immune system.
In the current study, the researchers looked at mice that were normal and healthy, but the researchers are currently engaged in experiments in which they use the same imaging technique to look at how goblet cells and dendritic cells might function differently when inflammation or infection occurs. They also plan to study mucus-producing goblet cells in other tissues, such as the lung, to determine whether they are working the same way elsewhere in the body.
INFORMATION:
McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, Knoop KA, Newberry RD, Miller MJ, Goblet cells deliver luminal antigen to CD103+ DCs in the small intestine. Nature, vol. 483(7389), March 15, 2012.
Funding for this research comes from grants awarded by the National Institute on Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) and by the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked fourth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Researchers identify unexpected player in intestinal immunity
2012-03-15
ELSE PRESS RELEASES FROM THIS DATE:
Mortgage Settlement Allotment to Struggling WI Homeowners: Too Little too Late?
2012-03-15
Of the $25 billion federal settlement funds for mortgage foreclosure abuses, Wisconsin will receive $140 million. The settlement money is being paid by J.P. Morgan Chase, Bank of America, Wells Fargo & Co, Citigroup and Ally (formerly GMAC), and is intended to help homeowners having difficulty making their mortgage payments and individuals who were the victims of improper foreclosures.
According to Assistant Attorney General Holly Pomraning in a recent TheNorthwestern.com article, Wisconsin's share of the settlement will be divided and distributed as follows:
- ...
CDC study shows outbreaks linked to imported foods increasing
2012-03-15
Foodborne disease outbreaks caused by imported food appeared to rise in 2009 and 2010, and nearly half of the outbreaks implicated foods imported from areas which previously had not been associated with outbreaks, according to research from the Centers for Disease Control and Prevention, presented today at the International Conference on Emerging Infectious Diseases in Atlanta.
"It's too early to say if the recent numbers represent a trend, but CDC officials are analyzing information from 2011 and will continue to monitor for these outbreaks in the future," said Hannah ...
Influenza 'histone mimic' suppresses antiviral response
2012-03-15
A team of researchers led by scientists at The Rockefeller University has identified a novel mechanism by which influenza interferes with antiviral host response. The finding, reported in this week's issue of the journal Nature, shows that the immunosuppressive NS1 protein of the influenza A virus hijacks key regulators of antiviral gene function by mimicking a core component of gene regulating machinery. The results they describe have major implications for our understanding of the biology of seasonal influenza virus and its pathogenesis. This research also suggests a ...
Nano spiral staircases modify light
2012-03-15
There was a lot of excitement a few years ago following the discovery of the DNA origami technique. The approach could be used to build nanoparticles of a given shape and size. However, real applications, such as nano-tweezers, remained out of reach. An international team of researchers led by Professor Tim Liedl of the Ludwig-Maximillians-Universitaet Muenchen and Professor Friedrich Simmel of the Technische Universitaet Muenchen have now succeeded in building nanoparticles using optically active DNA building blocks that can be used to modify light in very specific ways.
Coupling ...
Stanford scientists discover drug side effects, interactions using new computer algorithm
2012-03-15
STANFORD, Calif. -- A week ago, you started a new prescription medication for acne. Today, you feel dizzy and short of breath and have difficulty concentrating. Your symptoms are not listed in the package insert as possible side effects of the drug, but why else would you be feeling so odd?
Unfortunately, there's no easy answer. Clinical trials are designed to show that a drug is safe and effective. But even the largest trials can't identify irksome or even dangerous side effects experienced by only a tiny proportion of those people taking the drug. They also aren't designed ...
Molecular graphene heralds new era of 'designer electrons'
2012-03-15
Menlo Park, Calif. — Researchers from Stanford University and the U.S. Department of Energy's SLAC National Accelerator Laboratory have created the first-ever system of "designer electrons" – exotic variants of ordinary electrons with tunable properties that may ultimately lead to new types of materials and devices.
"The behavior of electrons in materials is at the heart of essentially all of today's technologies," said Hari Manoharan, associate professor of physics at Stanford and a member of SLAC's Stanford Institute for Materials and Energy Sciences, who led the research. ...
Many Jobless Turning to Social Security When Unemployment Ends
2012-03-15
Families throughout the nation continue to struggle financially. In fact, the prospect of economic stability continues to look so grim professionals have coined this period of time the Great Recession. Many depend on unemployment benefits to make ends meet during these difficult times, but what happens when they run out?
Now, more and more people are looking to Social Security Disability benefits when their unemployment ends. Whether people were disabled before their unemployment began or became disabled while receiving unemployment, Social Security Disability offers ...
Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
2012-03-15
In preclinical studies, researchers at SRI International and Astraea Therapeutics have recently evaluated the role of a new drug receptor target that shows promise for the treatment of drug addiction.
This potential new drug target belongs to a class of receptors called the nicotinic acetylcholine receptors (nAChRs). One subtype of nAChRs, called alpha4beta2 is a well-known target for nicotine's addictive effects and the therapeutic effect of the smoking cessation drug varenicline. SRI researchers are now studying another, lesser-known subtype, called alpha3beta4 nAChR, ...
What to Do When Nursing Home Neglect Leads to Dangerous Dehydration
2012-03-15
Dehydration is one of the most common forms of nursing home neglect. The risk of dehydration is particularly acute in patients who suffer from health problems that render them incapable of properly communicating their needs.
Nursing home dehydration can happen for a number of different reasons. Some patients aren't physically able to drink from a glass, either because they have difficulty swallowing or because they are unable to sit upright. In other cases, patients with cognitive or emotional difficulties may refuse certain beverages. In the worst cases the neglect ...
More than half of Americans doubt US global leadership in 2020
2012-03-15
WASHINGTON—March 14, 2012—More than half of likely voters doubt that the United States will be the No. 1 world leader in science, technology and health care by the year 2020, according to a new national public opinion poll commissioned by Research!America. The findings reveal deep concerns among Americans about the country's ability to maintain its world-class status in innovation, research and development before the next decade.
"A lackluster investment in science and innovation is driving fears among Americans about our world dominance in the years ahead," said Research!America ...